Rare diseases
Investigational molecules
Locations
Via Conca 71, 60126 Ancona, Italy
Clinical research activity is centred on acute myeloid leukemia, with attention to relapsed/refractory disease and NPM1-mutated AML. The sponsor’s trial portfolio reflects a focused interest in treatment-resistant myeloid malignancies managed within a hospital-based setting.
Research in this area is directed toward assessing antileukemic activity alongside safety and tolerability in patients with difficult-to-treat hematologic cancer.
Azienda Ospedaliero Universitaria Delle Marche runs clinical trials in conditions such as Acute myeloid leukaemia refractory, Acute myeloid leukaemia recurrent, among others.
Clinical trials run by this sponsor – those enrolling participants first.
ItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
